• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


32.9500 USD 0.5200 1.60%

As of 20:10:00 ET on 11/26/2014.

Snapshot for Merck KGaA (MKGAY)

Open: 32.6800 Day's Range: 32.6800 - 32.9500 Volume: 2,286
Previous Close: 32.4300 52wk Range: 25.2550 - 32.9500 1-Yr Rtn: +17.14%

Stock Chart for MKGAY

No chart data available.
  • MKGAY:US 32.9500
  • 1D
  • 1M
  • 1Y
Interactive MKGAY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MKGAY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 5.5240
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 4.7700
Est. PEG Ratio 0.9363
Market Cap (M USD) 42,977.79
Shares Outstanding (M) 387.73
30 Day Average Volume 3,553
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.32%
Cash Dividend (USD) 0.2956
Dividend Ex-Date 05/07/2014
5 Year Dividend Growth 4.83%
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MKGAY

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MKGAY

Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.

Karl-Ludwig KleyChairman-Mgmt Board/CEOMarcus KuhnertCFO/Member-Exec Board
Kai BeckmannChief Administration OfficerBernd ReckmannCEO:Chemicals
More Company Profile & Key Executives for MKGAY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil